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Abstract: 
An international consensus clinical practice statement issued in 2011 ranked psychogenic nonepileptic 
seizures (PNES) among the top three neuropsychiatric problems. An ILAE PNES Task Force was founded 
and initially charged with summarizing the current state of the art in terms of diagnosis and treatment, 
resulting in two publications. The first described different levels of diagnostic certainty. The second 
summarized current knowledge of management approaches. The present paper summarizes an 
international workshop of the ILAE PNES Task Force focusing on the current understanding and 
management of PNES around the world. We initially provide a knowledge update about the etiology, 
epidemiology and prognosis of PNES –in adults, and in special patient groups, such as children, the elderly 
and those with intellectual disability. We then explore clinical management pathways and obstacles to 
optimal care for this disorder around the world by focusing on a number of countries with different cultural 
backgrounds and at very different stages of social and economic development (UK, USA, Zambia, Georgia, 
China and Japan). While evidence-based methods for the diagnosis and treatment of PNES have now been 
described, and much is known about the biopsychosocial underpinnings of this disorder, this paper 
describes gaps in care (not only in less developed countries) which result in patients with PNES not having 
adequate access to healthcare provisions. A range of challenges emerge requiring solutions tailored to 
different healthcare systems. Continued attention to PNES by the ILAE and other national and 
international neurologic, psychiatric and health organizations, along with ongoing international 
collaboration should ensure that patients with PNES do not lose out as healthcare services evolve around 
the world. 
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A) Introduction 
An consensus clinical practice statement based on an international survey of experts carried out by the 
Commission on Neuropsychiatric Aspects of Epilepsy of the ILAE in 2011 ranked psychogenic non-
epileptic seizures (PNES) among the top three neuropsychiatric problems, next to anxiety / depression and 
psychotic disorder. 
1 
PNES are clinically defined as events resembling epileptic seizures but caused by 
psychological processes. Most are classified in the Diagnostic and Statistics Manual of Mental Disorders 
(DSM-5) as a conversion disorder.
 2
 Based on the results of the survey mentioned above, an ILAE PNES 
Task Force was founded and initially charged with summarizing the state of the art in terms of diagnosis 
and treatment. Two consensus publications resulted from this assignment. One established different levels 
of diagnostic certainty, depending on the data available to clinicians at the point of diagnosis. 
3
 The other 
summarized management approaches described in the literature. 
4
 Having completed these projects, the 
ILAE Task Force turned its attention to the topic “PNES around the world”. Prior studies have described 
treatment practices for PNES in the US, UK, Chile and Brazil. 
5-8
 The present paper summarizes 
presentations at a joint meeting of the ILAE PNES Task Force and the Japan Epilepsy Society in Nagasaki, 
Japan, in October 2015. After providing a brief knowledge update about PNES, we discuss some particular 
patient subgroups before exploring the challenges associated with the provision of care for patients with 
PNES around the world by focusing on six countries representing different cultures and stages of 
socioeconomic development. Finally, we consider approaches that may help to close gaps in diagnostic 
and treatment services for PNES in different countries.  
 
B) Knowledge update  
In the absence of well-resourced, formal epidemiological studies, the prevalence of PNES is very difficult 
to determine. Long delays from seizure onset to accurate diagnosis, and a tendency for patients with PNES 
to disengage from medical services after diagnosis mean that a substantial sub-population of patients with 
PNES disorders will not be easy to identify, even in developed countries. Epidemiological data form 
poorer countries is virtually lacking altogether. One estimate based on the number of patients referred to 
epilepsy centers who are thought to have severe epilepsy but turn out to have PNES yielded a possible 
prevalence range of 2 to 33 /100,000 (0.002 - 0.033%). 
9
 Alternatively, one could generate an estimate 
based on the assumption of a similar long-term course as for epilepsy, and an extrapolation from incidence 
figures. Following this approach, an incidence figure of 5/100,000/year would yield an estimated 
prevalence of approximately 1/10 that of epilepsy, or 5/100,000.   
 
The incidence of PNES is somewhat easier to study and has recently been determined to be 
4.09/100.000 in a study based in the United Kingdom. 
10
 To date, comparative differences in the incidence 
and prevalence of PNES around the world have not been studied. However, research from many countries 
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documents that PNES is not a disorder that only exists in the developed world. In addition to presentations 
closely resembling those in Western and other highly industrialized societies, PNES-like states are also 
recognized in some cultures around the world as a cultural phenomenon.
 11
 
A “gold standard” diagnosis of PNES is based on a history consistent with PNES and the recording of 
a typical event with semiological features of PNES but no epileptiform activity in the EEG before, during 
or after the ictus. The combination of a history, semiology and video EEG findings consistent with PNES 
provides the level “documented” PNES. However, the recognition of PNES diagnoses with lower levels 
of certainty is important, because not all sites (or patients) around the world have access to video EEG and 
clinicians and patients may have to make treatment choices (for instance about stopping inappropriate 
antiepileptic drugs or commencing psychological treatment) when the diagnosis is not completely certain. 
These levels include “clinically established”, “probable”, and “possible”, in descending order. 
3
   
Our understanding of the etiology of PNES has improved significantly over the last two decades. 
13
 PNES 
are a multifactorial biopsychosocial disorder. No single mechanism or contributing factor has been 
identified as necessary and sufficient to explain the disorder in all cases. 
14,15
 Traditionally conversion 
disorder, dissociative mechanisms and stress-related factors have been considered in psychopathological 
models of PNES. 
13, 16
 However, more comprehensive, integrative models of PNES have been developed, 
which take account of a wider range of possible pathopsychological mechanisms including abnormal 
arousal and inhibition (see figure 1) [Voon V, et al. Functional Neuroanatomy and Neurophysiology of 
Functional Neurological Disorders (Conversion Disorder). J Neuropsychiatry Clin Neurosci 
2016;28(3):168-90, published by American Psychiatric Association] 
17,18
 Although patients do not 
universally report trauma or neglect in early life, studies using different self-report and experimental 
methodologies have identified adverse childhood experiences as a factor predisposing to the development 
of PNES in later life. 
19,20
 Many (but not all) patients with PNES also report trauma in adult life, potentially 
leaving them with symptoms of Posttraumatic Stress Disorder (PTSD), such as hypo- or hyperarousal and 
flashbacks. 
21
 To date, no research has explored differences in the psychiatric comorbidity or the 
psychopathological underpinnings of PNES comparing different cultures or countries around the world, 
although studies have reported differing rates of previous sexual abuse in women with PNES in Eastern 
and Western countries. 
21-24 
 
The burden associated with PNES is considerable for health care systems and societies at large, as well 
as for affected individuals and their families. 
25
 It is estimated that 20-30% of patients referred to epilepsy 
centers with intractable seizures have been misdiagnosed with epilepsy - the vast majority of these patients 
are eventually diagnosed with PNES. 
26
 In addition to the direct health care costs associated with PNES, 
indirect costs caused by loss of employment, and reduced availability for household work by patients and 
caregivers have great societal impact. 
27
 Several studies have found that direct healthcare costs decline 
following the diagnosis of PNES because of substantial reductions in health care resource utilization. 
28,29
 
The early reduction in healthcare use is often sustained over the longer term, although long-term 
employment outcomes do not seem favorable. 
30,31
 Randomized clinical trials (RCTs) now provide an 
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evidence-base for different psychological treatment approaches for PNES (although it is not certain to 
what extent the findings of these studies can be generalized to poorer countries). 
12
 Although the health 
economic effects of psychological treatments have not been studied in randomized trials, observational 
studies suggest that psychological interventions can reduce health care costs associated with PNES.
32
 
 
C) PNES in different subpopulations 
PNES is well documented in children, 
33,34
 however, there is a lack of population-based data on the 
prevalence or incidence of PNES in the pediatric population. Studies reveal better outcomes for children 
than adults with PNES. 
35
 Studies of children up to 12 year of age have identified the following patient 
characteristics: PNES have been reported from the age of 3 years 
32
; unlike in adults, there is no female 
predominance; motor inhibition (dialeptic attacks) was more common than hyper-motor type events 
34,36
; a 
history of physical or sexual abuse is reported less commonly by pediatric than adult patients.
 33
 School 
phobia or difficulties in school (including bullying, specific learning difficulties or unrealistic expectations) 
have been reported as the most common precipitating or perpetuating factors. 
33
 A number of neurologic, 
psychiatric and psychosocial risk factors have been reported for children and adolescents with PNES. 
37,38  
PNES are usually thought of as a disorder of younger adults. They are likely to be under-recognized 
in the elderly. A number of studies have identified older patients who have had PNES long-term 
39-41
 and 
patients whose PNES have started in later life. 
42
 One study showed that in patients with a PNES onset in 
later life, seizures often seemed to be precipitated by health-related traumatic experiences. 
43
 In the same 
study, patients with late onset PNES had better baseline psychological health and reported a lower rate of 
sexual abuse than younger adults with PNES. Unlike in younger adults (but similar to children), the gender 
ratio was even. There may be a tendency for older adults to have PNES with convulsive movements in the 
form of low amplitude high frequency tremors with partially preserved responsiveness. 
41,42
 Physiological 
non-epileptic events such as postural and cardiac syncope occur more commonly in elderly patients 
41
 and 
need to be considered carefully in the differential diagnosis of seizures.
43
 
Patients with intellectual disability (ID) make up another important PNES subgroup, and studies 
reveal that the proportion of patients with PNES and comorbid ID is similar to that of patients with PNES 
and additional epilepsy (i.e. about 10%).
 44,45
 One study focusing on patients with PNES and ID suggested 
that this particular subgroup of patients differed from those with PNES but no ID in a number of ways. In 
the group with ID, there was a trend towards a male preponderance, relative paucity of antecedent sexual 
abuse, frequent episodes of psychogenic nonepileptic status, as well as a greater proportion of patients in 
whom situational or emotional triggers immediately preceding individual PNES were reported. 
46
 Gates 
and Erdahl 
7
proposed “a reinforced behavior pattern” as a particularly important pathogenetic factor 
leading to PNES in patients with comorbid ID, 
47
  an idea re-emphasized in the study of Magaudda et al.. 
48
 
In view of the somewhat different etiology of PNES in this patient subgroup, treatment may need to be 
different as well. A therapeutic approach combining the modification of the patient’s environment and their 
mindset may be particularly useful. 
49
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Unfortunately, no data is available about PNES in these specific subgroups from less highly developed 
regions of the world. However, awareness of these patient subgroups needs to be promoted around the 
world, to ensure that PNES are not overlooked or mistreated in these subpopulations. 
 
D) PNES around the world 
The following section describes services for PNES in six countries with different sociocultural 
backgrounds and at different stages of economic development. These examples provide an impression of 
the range of difficulties patients with PNES are likely to encounter when they try to access diagnostic or 
treatment services (see Table 1 for an overview). 
Zambia 
Background: Epilepsy is the most common neurological condition, affecting 14.5/1000 of the population. 
50
 Epilepsy is not considered a “normal medical condition” by the population but a mental disorder or form 
of “insanity”. The situation is not better for patients with PNES. 
Services: Most regional health care is provided by Clinical Officers in psychiatry or general medicine with 
limited training. These are not trained physicians. Expert care is centralized in the capital, Lusaka. This 
makes it very difficult for patients to access diagnostic facilities or benefit from the advice of medical 
specialists. 
Diagnosis: Regional health centers have no access to EEG, video-EEG monitoring, 24-hour EEG or high 
quality MRI/ CT. PNES diagnoses are mainly made by psychiatrists, neurologists (only present in very 
small numbers and usually found centrally in tertiary hospitals), or by Clinical Officers in psychiatry and 
general medicine. 
Treatment: An estimated 80% of people with epilepsy receive treatment from traditional healers who do 
not refer the patients to health professionals even if they fail to improve with their treatment.
50,51
 It is 
unknown how many patients with PNES access traditional healers. 
Service gaps: The referral chain from primary care via provincial health care institutes to the final tertiary 
medical centers does not work well. As a result, patients may not be referred, or referrals come directly to 
tertiary centers without prior screening, which are consequently overloaded with patients. No support 
groups or education and information materials are available. 
Proposed solutions: There is a strong need to increase awareness about PNES, develop the infrastructure 
for the diagnosis and management of patients with PNES, develop proper teaching and training modules 
for Clinical Officers and non-specialists, increase the number of health professionals trained in the 
management of PNES and to develop a strong referral system.  
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China 
Background: Large Asian country, population 1.4 billion, GDP per capita 7,590 USD. Over 90% of the 
population are Han Chinese, but there are many smaller cultural and ethnic groups. There are highly 
variable levels of population density and urbanization. Physical or sexual abuse is less often reported by 
PNES patients than in Western studies. 
22 
Services: Almost all municipal hospitals have routine EEG and MRI/CT, and many have video-EEG 
monitoring units, but these tests are not available in township hospitals. PNES may be diagnosed by 
doctors in different clinical specialties. PNES are still widely called “pseudoseizures” or “hysteria”. More 
comprehensive diagnostic assessments and treatments involving video-EEG monitoring and cognitive 
behavioral therapy (CBT) are only available in larger centers with psychiatry departments. 
Diagnosis: About 18% of patients with intractable seizures admitted for video-EEG to the Epilepsy Unit in 
the West China Hospital are actually found to have PNES. About 1/3 of these were initially misdiagnosed 
as epilepsy. 
22,52
 Misdiagnosis rates of 2/3 have been found in patients with more chronic seizure disorders. 
53
  
Treatment: At present, most patients with PNES in China do not have access to CBT or other forms of 
psychotherapy. The most common treatment for PNES in China involves the prescription of psychotropic 
drugs. Some patients do not receive any treatment at all. 
22
 
Service gaps: The referral system in China is not well developed. Many patients from rural areas and with 
poor educational or economic conditions choose to visit local clinics, in which PNES are often 
misdiagnosed and mistreated, while better placed or informed patients come to tertiary centers directly, 
where they may receive a better level of medical service. 
Proposed solutions: There is an urgent need for the development of standard referral, diagnostic and 
treatment processes for PNES in urban and rural areas of China. 
 
Georgia 
Background: Predominantly Christian country at the boundary between Eastern Europe and Asia, 
population 3.7 million, GDP per capita 4,435USD. The mixed cultural background has produced a 
historically high level of tolerance toward minority religions and ethnic groups. Minority groups have 
maintained distinct and separate socio-cultural development, and PNES are observed more commonly in 
these groups than the rest of the population. 
54
 
Services: Specialist medical services were established in 1974 when an Epilepsy Centre was founded at 
the Tbilisi Sarajishvili Institute of Neurology. A standard diagnostic and treatment protocol has been 
formulated. From the end of the 1990s, non-pharmacological treatment have been initiated by 
neuropsychiatrists providing therapeutic support for patients with PNES admitted to the Institute. 
Diagnosis: All diagnostic techniques are available, but high resolution MRI and video-EEG monitoring 
are only offered in Tbilisi (the capital), and investigations usually have to be paid for by patients. Staff at 
the Epilepsy Centre in Tbilisi have developed a positive diagnostic approach to PNES aiming to identify 
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psychopathological processes accounting for PNES. The diagnostic process is generally managed by a 
neurologist or epileptologist. 
55,56
 
Treatment: The provision of non-pharmacological services (i.e., psychotherapy) is a major problem due 
to a shortage of trained specialists, especially cognitive-behavioral therapists. Both health professionals 
and patients tend to prefer combined pharmacological and psychotherapeutic intervention (non-CBT), 
where it is available. 
Service gaps: Despite the early introduction of a specialized epilepsy service in Georgia, currently, due to 
a fundamental reorganization of the health care system, the treatment of chronic neurological disorders is 
not a government health priority. Private insurance companies cover strictly diagnostic laboratory 
investigations, however, not all citizens (especially not all elderly and socially vulnerable persons) have 
private medical insurance. The low-income environment and economically limited health care system pose 
particular challenges for patients with PNES 
Proposed solutions: Efforts of health policy makers and experts in the field should be directed to establish 
more socially-oriented policies for patients with PNES. Intensive training of care providers, introducing 
CBT and knowledge exchange with international medical centers could raise diagnostic and treatment 
standards while maintaining a culture-specific management approach. 
 
Japan 
Background: Highly industrialized, culturally and ethnically uniform East Asian country, population 126 
million, GDP per capita 36,194 USD. PNES have been studied in Japan since the early 1950s. 
57
  
Services: From the early 1900s psychiatrists familiar with epilepsy have played a central role in the 
diagnosis and treatment of PNES. While this situation is changing, a substantial number of psychiatrists 
are still able to provide PNES patients with a long-term therapeutic approach. 
58
 
Diagnosis: All diagnostic techniques are widely available. High resolution MRI and video-EEG 
monitoring are offered in every municipal epilepsy center. Investigations are mostly covered by public 
health insurance but have to be paid partially by patients (with an upper limit or patient contributions). In 
2009, the Japan Epilepsy Society published a guideline for the diagnosis and management of PNES in 
2009.
 59
 Along with video-EEG monitoring, the guideline emphasized the significance of longitudinal 
observation with therapeutic intervention. 
Treatment: Along with psychotherapy inclusive of CBT, the PNES treatment guideline of the Japan 
Epilepsy Society emphasized the significance of environmental adjustment, especially in patients with ID, 
aiming to reduce precipitating and perpetuating factors. Most patients with intractable PNES are eventually 
referred to psychiatrists.   
Service gaps: While experts at epilepsy centers are able effectively to differentiate between PNES and 
epilepsy, the number of psychiatrists involved in the management of patients with PNES has gradually 
decreased. 
58
 As a result, the gap between the diagnosis of PNES and treatment is increasing in Japan (as it 
may be in other countries where there is a divide between psychiatry and neurology).  
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Proposed solutions: It will be crucial not only to educate physicians/neurologists interested in epilepsy 
about PNES but also nurses, psychologists or occupational therapists. In addition, young psychiatrists need 
to be educated about epilepsy and PNES to prevent further retreat of psychiatrists from epilepsy care.  
 
United Kingdom 
Background: Highly industrialized, culturally and ethnically diverse Western European country, 
population 65 million, GDP per capita 46,297 USD. The National Health Service provides universal 
healthcare for all, dependent on clinical need and free at the point of delivery. The National Institute of 
Clinical Excellence (NICE) recommends diagnostic and treatment pathways on the basis of evidence 
Services: PNES are usually diagnosed by general neurologists. All neurologists have access to routine 
EEG, most to video-EEG. Access to epilepsy/PNES experts is limited. Treatment is provided by clinical 
psychology / psychotherapy services, typically in community or mental health settings. Although some 
psychotherapy provision exists almost everywhere, access to psychotherapy with expertise in the treatment 
of PNES is very limited. Most psychiatrist only have a very limited understanding of PNES (or epilepsy). 
Diagnosis: Despite widespread access to video-EEG, 30% of PNES diagnoses are made on clinical 
grounds. 
6
 There are no national guidelines for the diagnosis of PNES. The diagnosis is communicated by 
neurologists. Many use leaflets or websites to support the explanation. Most patients are referred to 
psychologists or psychiatrists for further exploration. 
Treatment: There are no U.K. national treatment guidelines for PNES. Most patients are referred for 
psychological treatment, but only receive a small number of sessions from therapists not familiar with 
PNES. Exceptions exist in centers of excellence. A large multicenter RCT of a CBT approach for PNES is 
underway. 
60
 
Service gaps: Despite improving knowledge about PNES most patients are initially misdiagnosed as 
having epilepsy, and the mean delay between PNES manifestation and diagnosis is around 5 years. 
Psychiatrists, psychologists and psychotherapists not working in epilepsy centers have a very limited 
understanding of PNES, and access to longer psychotherapy programs (more than six sessions) is limited. 
Proposed solutions: The completion of the multicenter CBT RCT may generate the evidence required to 
persuade NICE (National Institute for Clinical Excellence) to issue guidance for the diagnosis and 
treatment of PNES.
 60
 The integration of training modules about PNES in neurological and psychiatric 
specialist training may improve understanding of the disorder in the future. 
 
United States 
Background: Highly industrialized country with an ethnically, culturally and religiously diverse native-
born and immigrant population of 322 million, with GDP per capita 55,805 USD. Urban and rural settings 
have a wide array of health care services. Provisions covered by public and private insurance have been 
expanded to formerly uninsured by the Affordable Care Act of 2010. 
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Services: Routine EEG, ambulatory EEG and video EEG are available in tertiary care epilepsy referral 
centers across the country. Treatment is provided at a handful of epilepsy centers where outpatient 
individual and group therapy is offered for adults with PNES. The majority of US psychiatrists and 
psychologists, however, do not follow up or treat patients with PNES or other conversion disorders.  
Diagnosis: Video-EEG is available at all Level 3 and 4 Epilepsy Centers and at Veteran Administration 
(VA) Epilepsy Centers of Excellence (ECoE). There are no national guidelines for the diagnosis of PNES, 
however, video EEG is accepted as the diagnostic gold standard. The diagnosis is communicated by 
neurologists, with some epilepsy unit teams incorporating mental health providers. Patients are referred to 
mental health providers but not all engage. 
5
 
Treatment:. There are no U.S. national treatment guidelines for patients with PNES. A pilot multicenter 
RCT using a manualized cognitive behavioral-informed psychotherapy revealed decreased seizures, 
comorbid psychiatric symptoms and improved quality of life in the therapy arms.
12
  The seizure therapy 
treatment workbook is being used by patients and providers in the VA Epilepsy Centers of Excellence 
(ECoE) and some US Level 4 Epilepsy Centers.  
Service gaps: Despite diagnosing many patients with PNES, most civilian Level 4 Epilepsy Centers still 
do not provide treatment for patients with PNES. A growing number of VA ECoEs provide treatment for 
Veterans with PNES using trained providers on site and via computer video telehealth.
61,62
 
Proposed solutions: As more US civilian and VA hospitals develop clinics that are successfully treating 
patients with PNES and with epilepsy using the Seizure Workbook, 
63, 64
 more sites will be trained to 
deliver evidence-based interventions.  
 
E) Addressing gaps in diagnostic and treatment services for PNES  
The reduction in quality of life experienced by people with PNES is well documented and is a major global 
public health issue.
65  
Our understanding of the management of this condition has improved significantly 
over the past decade. Unfortunately, clinical studies showing what is possible in terms of treatment and 
strong evidence of personal and public health need are unlikely in themselves to alter care. We suggest that 
six key themes can be addressed, which combine to offer a route map nationally and globally to build the 
care of people with PNES over the next decade. 
Access to diagnostic process. We have established criteria for diagnosis, with minimum standards to allow 
their use in global health care settings. There is a need to develop country-specific resources, at least to 
provide minimum diagnostic services to ensure that all people can have a diagnosis made and 
communicated to an appropriate standard.
3
 
Development of treatment pathways. The development of evidence-based treatments for PNES has 
advanced significantly in the last ten years.
4
 However, interventions have not as yet been universally 
adopted, specifically by psychological and psychiatric service providers. Treatment pathways need to be 
developed either within epilepsy services or generic psychiatric services. Such pathways must be adapted 
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to local service structures but must be inclusive to ensure people with PNES are not excluded, because 
they fall outside the range of treatments routinely addressed by psychological service providers (e.g., for 
mood or anxiety disorders). 
Providing services for patients with chronic PNES disorders. Whilst some patients with PNES remit 
simply after a decent explanation of the diagnosis with or without ensuing short term CBT programs, 
10,12,17
 a substantial number of patients need longer-term psychotherapeutic or mental health interventions 
either because of continuing PNES or background psychosocial problems which remain unchanged even 
after the cessation of PNES.
 30,66
 Whilst most recent research efforts on PNES have been directed either at 
the communication of the diagnosis or short term treatments, the latter group of patients have been largely 
neglected, even in well-resourced Western countries. 
30,65
  
Closing the gap between neurology and psychiatry. The ongoing and increasing process of 
subspecialisation across all fields of medicine has contributed to a widening gap between neurology and 
psychiatry in many countries around the world. For many patients with PNES this gap means that different 
medical specialities are responsible for the diagnosis and treatment of their disorder. This discontinuity of 
the diagnosis-treatment pathway causes many patients not to access treatment after a diagnosis of PNES 
has been made. Better education of neurologists about the management of the mental health problems they 
commonly encounter (including PNES) and of psychiatrists about seizures (epileptic and non-epileptic) 
and closer working relationships between health professionals could help to close this gap.  
The individualization of care – a blue print for conversion / dissociative disorders. The dominant theme of 
healthcare is towards a more individualized approach. The approach is underpinned by a credo that all 
conditions will be understandable on an individual genetic level. In the field of PNES this goal currently 
seems beyond reach but recent progress in the neurobiological and psychological underpinnings of PNES 
will hopefully allow us better to tailor treatments for this heterogeneous patient population to individual 
patients. 
67,68
 The deepening understanding of this condition will hopefully also mean that agencies funding 
research and service developments will increasingly recognize the importance of this disabling disorder 
and that stigma will be reduced. 
69 
Ensuring that patients are well-informed & empowered. This is possibly the largest challenge, but one 
which must be achieved in order for change to occur. In many branches of medicine patients are being 
empowered as their own advocates to navigate their health journey. The same process needs to be 
developed for people with PNES. PNES patient groups in the USA and the UK demonstrate that it is 
possible to develop patient advocates which can support professionals in the drive to improve access to 
diagnostic and treatment services.  
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F) Conclusion 
The Japan PNES conference built on prior workshops and identified gaps in care for patients with PNES 
not only in poor countries but around the world. Apart from highlighting that, just like epilepsy, PNES is a 
global problem, this article demonstrates how patients with this disorder and professionals keen to help 
them face different problems around the world. This article hints at some of the possible solutions. Whilst 
many of the recent scientific findings about the etiology and treatment of PNES summarized here are 
likely to be universally true, optimal solutions or improvements will have to be specific to individual 
countries reflecting different cultural traditions. 
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Bullet points: 
This paper summarizes the discussions focusing on the current understanding and management of PNES 
around the world.  
We initially provide a knowledge update about the etiology, epidemiology, subgroup of PNES 
We then demonstrate clinical management and obstacles for this disorder in six countries (UK, USA, 
Zambia, Georgia, China and Japan)  
 
Figure 1:  from Voon V, et al. Functional Neuroanatomy and Neurophysiology of Functional Neurological 
Disorders (Conversion Disorder).  J Neuropsychiatry Clin Neurosci 2016;28(3):168-90.  With permission 
from Copyright ©2016 American Psychiatric Association. All rights reserved. 
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Table 1 PNES around the world 
 HDI: The Human Developmental Index (HDI) is a composite statistic of life expectancy, education, and income per capita 
indicators.; Psychologists here include cognitive behavioral therapists     
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